Home › Employers › Arch Medical Solutions - Philadelphia, LLC
Arch Medical Solutions - Philadelphia, LLC: H-1B salaries and sponsorship
Arch Medical Solutions - Philadelphia, LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $92,000.
Does Arch Medical Solutions - Philadelphia, LLC sponsor H-1B visas?
Arch Medical Solutions - Philadelphia, LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 16, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Quality Assurance Engineer | 2 | $91,000 |
| Manufacturing Engineer | 1 | $115,566 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 1 | $115,566 |
| FY2026 | 2 | $91,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Quality Assurance Engineer | $92,000 Level II | Huntingdon Valley, PA | Jun 16, 2026 | Oct 1, 2026 | Certified |
| Quality Assurance Engineer | $90,000 Level I | Huntingdon Valley, PA | Apr 23, 2026 | Oct 1, 2026 | Certified |
| Manufacturing Engineer | $115,566 Level III | Huntingdon Valley, PA | Oct 30, 2024 | Apr 4, 2025 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).